Real-time enrollment status for this advanced solid tumor clinical trial
Current Status
Recruiting
Checked: October 13, 2026 at 7:57 AM UTC
| NCT Number | NCT06859762 |
| Recruiting Status | Recruiting |
| Condition | Advanced Solid Tumor |
| Phase | PHASE1 |
| Target Enrollment | 630 participants |
| Active Locations | 12 sites in the US |
| Sponsor | MediLink Therapeutics (Suzhou) Co., Ltd. |
| Last Updated on CT.gov | September 18, 2026 (3 weeks ago) |
As of October 13, 2026: Clinical trial NCT06859762 is currently recruiting participants. This phase1 study for advanced solid tumor is actively seeking new participants at 12 locations across the United States. The study is sponsored by MediLink Therapeutics (Suzhou) Co., Ltd.. This status information is automatically verified from the official ClinicalTrials.gov registry.
Yes, NCT06859762 is actively recruiting participants as of October 13, 2026. You can check eligibility and apply through HelloStudys.
This trial is recruiting at 12 locations in the United States. View all available locations on the full study page.
Check your eligibility and express interest by completing the application form on the study page. A research coordinator will follow up to discuss next steps.
The official ClinicalTrials.gov record for NCT06859762 was last updated 3 weeks ago (September 18, 2026). HelloStudys verifies this status automatically.